Document Detail


Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients.
MedLine Citation:
PMID:  20860877     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The neurotrophin brain-derived neurotrophic factor (BDNF) plays a critical role in neuronal survival, synaptic plasticity, and memory. Several recent studies have demonstrated altered BDNF serum levels in Alzheimer's disease (AD) patients. However, the association of BDNF serum levels with the rate of cognitive decline in AD patients is still unclear. We demonstrate that BDNF serum levels are significantly decreased in AD patients with fast cognitive decline [decrease of Mini-Mental State Examination (MMSE) score >4/yr; n=12] compared to AD patients with slow cognitive decline (decrease of MMSE score ⩽4/yr, n=28) and show a significant correlation with the rate of cognitive decline during 1 yr follow-up. These results suggest that higher BDNF serum levels are associated with a slower rate of cognitive decline in AD patients. Further longitudinal studies are necessary to elucidate the kinetics and the potential role of serum BDNF as a surrogate marker of disease progression in AD patients.
Authors:
Christoph Laske; Konstantinos Stellos; Nadine Hoffmann; Elke Stransky; Guido Straten; Gerhard W Eschweiler; Thomas Leyhe
Related Documents :
19575407 - Serum s100b in elderly patients with and without delirium.
20479357 - Clinical staging and disease progression in frontotemporal dementia.
8939277 - Apoe-epsilon 4 in patients with alzheimer disease and vascular dementia.
21031607 - Demonstration of safety in alzheimer's patients for intervention with an anti-hypertens...
8104207 - The emergence of vancomycin resistance in renal dialysis.
9625047 - Evaluation of a homogeneous assay for high-density lipoprotein cholesterol: limitations...
Publication Detail:
Type:  Journal Article     Date:  2010-09-22
Journal Detail:
Title:  The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)     Volume:  14     ISSN:  1469-5111     ISO Abbreviation:  Int. J. Neuropsychopharmacol.     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-03-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9815893     Medline TA:  Int J Neuropsychopharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  399-404     Citation Subset:  IM    
Affiliation:
Department of Psychiatry and Psychotherapy, Eberhard-Karls Universität Tübingen, Tübingen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Alterations in the central CRF system of two different rat models of comorbid depression and functio...
Next Document:  Association study of a functional catechol-O-methyltransferase (COMT) Val108/158Met polymorphism and...